AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991)
Authors: PETTI MC SPADEA A AVVISATI G SPADEA T LATAGLIATA R MONTEFUSCO E COSENZA M MALAGNINO F
Citation: Mc. Petti et al., POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991), Leukemia, 12(6), 1998, pp. 869-874
HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: PETTI MC SPIRITI MAA MONTEFUSCO E REDI R MANCINI M COMANDINI A DELIA GM MANDELLI F
Citation: Mc. Petti et al., HIGH-DOSE HYDROXYUREA (HIGH-HY) IN THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 222-222
LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA
Authors: TURA S ROSTI G DEVIVO A BONIFAZI F FIACCHINI M BACCARANI M RUSSO D FANIN R ZUFFA E MONTEFUSCO E
Citation: S. Tura et al., LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA, Blood, 92(5), 1998, pp. 1541-1548
BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN-VITRO PURGING AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE
Authors: DEFABRITIIS P PETTI MC MONTEFUSCO E DEPROPRIS MS SALA R BELLUCCI R MANCINI M LISCI A BONETTO F GEISER T CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN-VITRO PURGING AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE, Blood, 91(9), 1998, pp. 3156-3162
ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
Authors: MONTEFUSCO E PETTI MC ALIMENA G LATAGLIATA R CELESTI F CAPRIA S AMADORI S AVVISATI G MANDELLI F
Citation: E. Montefusco et al., ETOPOSIDE, INTERMEDIATE-DOSE CYTARABINE AND CARBOPLATIN (VAC) - A COMBINATION THERAPY FOR THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA, Annals of oncology, 8(2), 1997, pp. 175-179
USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS
Authors: CARLOSTELLA C REGAZZI E ANDRIZZI C SAVOLDO B GARAU D MONTEFUSCO E VIGNETTI M MANDELLI F RIZZOLI V MELONI G
Citation: C. Carlostella et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS, Haematologica, 82(3), 1997, pp. 291-296
LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY
Authors: BARBUI T DEGAETANO G FINAZZI G LANDOLFI R MARCHIOLI R PATRONO C TOGNONI G CAPANI F DECARLI A GAMBI D NENCI GG TURA S MANDELLI F ROSSIFERRINI P CORTELAZZO S VESTRI O FINELLI C NOCENTINI F POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGILIONE R ANGELI G DIBLASIO A DIPASQUALE A KRAMER V MARFISI RM OLIVIERI M SCIULLI L SPOLTORE R MONTEFUSCO E SPADEA A CAROTENUTO M NOBILE M MORELLI A RESEGOTTI L VASINO MAC RODEGHIERO F RUGGERI M
Citation: T. Barbui et al., LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY, British Journal of Haematology, 97(2), 1997, pp. 453-456
AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER IN-VITRO TREATMENT WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE
Authors: DEFABRITIIS P PETTI MC MONTEFUSCO E DEPROPRIS M BELLUCCI R MANCINI M LISCI A CALLABRETA B MANDELLI F
Citation: P. Defabritiis et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER IN-VITRO TREATMENT WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE, Blood, 90(10), 1997, pp. 1875-1875
A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA
Authors: AMADORI S PICARDI A FAZI P TESTI AM PETTI MC MONTEFUSCO E MANDELLI F
Citation: S. Amadori et al., A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 10(5), 1996, pp. 766-768
CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON
Authors: ALIMENA G LAZZARINO M MORRA E MANCINI M CEDRONE M MONTEFUSCO E MERANTE S MELONI G BERNASCONI P RONDINELLI MB BERNASCONI C MANDELLI F
Citation: G. Alimena et al., CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON, Leukemia, 10(4), 1996, pp. 615-618
2 BCR-ABL JUNCTION PEPTIDES BIND HLA-A3 MOLECULES AND ALLOW SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES
Authors: GRECO G FRUCI D ACCAPEZZATO D BARNABA V NISINI R ALIMENA G MONTEFUSCO E VIGNETI E BUTLER R TANIGAKI N TOSI R
Citation: G. Greco et al., 2 BCR-ABL JUNCTION PEPTIDES BIND HLA-A3 MOLECULES AND ALLOW SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES, Leukemia, 10(4), 1996, pp. 693-699
LACK OF EFFICACY OF A DOUBLE AUTOGRAFT PROGRAM TO PROLONG SURVIVAL OFCHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN ELASTIC TRANSFORMATION
Authors: CAPRIA S VIGNETTI M MONTEFUSCO E CARDILLO AMF SIMONE F MELONI G
Citation: S. Capria et al., LACK OF EFFICACY OF A DOUBLE AUTOGRAFT PROGRAM TO PROLONG SURVIVAL OFCHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN ELASTIC TRANSFORMATION, Haematologica, 81(4), 1996, pp. 349-351
TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON
Authors: PETTI MC LATAGLIATA R AVVISATI G SPIRITI MAA MONTEFUSCO E SPADEA A MANDELLI F
Citation: Mc. Petti et al., TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON, British Journal of Haematology, 95(2), 1996, pp. 364-367
THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS
Authors: LATAGLIATA R PETTI MC DIVERIO D FAZI P MECAROCCI S MONTEFUSCO E REDI R SPADEA A TORROMEO MC AVVISATI G
Citation: R. Latagliata et al., THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS, Blood, 88(10), 1996, pp. 3425-3425
CLONALITY STUDIES REVEAL DIFFERENT DEGREES OF STEM-CELL INVOLVEMENT IN PH-NEGATIVE AND PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIAS
Authors: SAGLIO G ROSSO C CILLONI D SERRA A CALCIA F VISCHIA F MONTEFUSCO E LOCOCO F GUERRASIO A
Citation: G. Saglio et al., CLONALITY STUDIES REVEAL DIFFERENT DEGREES OF STEM-CELL INVOLVEMENT IN PH-NEGATIVE AND PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIAS, Blood, 88(10), 1996, pp. 2323-2323
IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: DEFABRITIIS P AMADORI S PETTI MC MANCINI M MONTEFUSCO E PICARDI A GEISER T CAMPBELL K CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Leukemia, 9(4), 1995, pp. 662-664
CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/
Authors: BACCARANI M TURA S RUSSO D BACCARANI M ZACCARIA A SAGLIO G GUERRASIO A MARTINELLI G ZUFFA E TESTONI N FARABEGOLI P ZAMAGNI MD FANIN R DAMIANI D DEMILIO A BATTISTA R SPECCHIA G LISO V DITUCCI A BROCCIA G MONTEFUSCO E MANDELLI F RAMBALDI A BARBUI T BODENIZZA CA CAROTENUTO M ROTONDO SG AMBROSETTI A PERONA G LUCIANO L ROTOLI B RONCO F NOBILE F TABILIO A LIBERATI A MARTELLI M GRIGNANI F PARDINI S LONGINOTTI M GENTILINI I COSER P LEONI F CIOLLI S MORRA E BERNASCONI C FERRERO D PILERI A LEONI P DANIELI G ABBADESSA A BRUZZESE L TRINGALI S CARONIA F GALIENI P DISPENSA E NOVARINO A CAPUCCI A IZZI T NOSARI A PIZZUTI M RICCIUTI F VASINO AC RESEGOTTI L CAPALDI A GIOVANNELLI E
Citation: M. Baccarani et al., CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/, Leukemia, 9(10), 1995, pp. 1648-1652
POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS
Authors: RIUNITI O BARBUI T FINAZZI G NEGRI M SUD CMN DEGAETANO G MARCHIOLI R TOGNONI G PATRONO C LANDOLFI R DITORRETTE ON LEONI P RUPOLI S CORTELAZZO S VESTRI O TURA S FINELLI C NOCENTINI F ANGELI G DIPASQUALE A KRAMER V MARFISI R OLIVIERI M SCIULLI L SPOLTORE R CAREGGI P FERRINI PR GROSSI A LONGO G NIGUARDA O DECATALDO F GARGANTINI L BAUDO F GERARDO S POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGLIONE R MANDELLI F MONTEFUSCO E SPADEA A GIOVANNI S CAROTENUTO M NOBILE M MORELLI R MOLINETTE O RESEGOTTI L VASINO MAC BARTOLO OS RODEGHIERO F RUGGERI M ROSSIFERRINI P
Citation: O. Riuniti et al., POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS, Annals of internal medicine, 123(9), 1995, pp. 656
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP
Authors: CERVANTES F ROBERTSON JE ROZMAN C BACCARANI M TURA S GOMEZ GA BRAUN TJ CLARKSON BD PEREIRA A ZACCARIA A ZUFFA E MANDELLI F ALIMENA G MONTEFUSCO E RUSSO D FANIN R GRIGNANI F MARTELLI MF MORRA E BERNASCONI C CAJOZZO A PERONA G AMBROSETTI A LEONI P LOMBARDO M DELFINI C TORLONTANO G PORCELLINI A DEMILIO A BATTISTA R LEONI F GUGLIELMO P GIUSTOLISI R DECATALDO F NOSARI A RIZZOLI V MANGONI M CARNEVALI C LISO V SPECCHIA G BAJETTA E BROCCIA G DITUCCI A BUSINCO A BRUZZESE L ABADESA A LANZI E ALBERTI A NERI A RONCO F TONATO M GRIFONI V
Citation: F. Cervantes et al., LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP, British Journal of Haematology, 87(2), 1994, pp. 293-300
PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS
Authors: SPADEA A PETTI MC SPIRITI MAA AVVISATI G LATAGLIATA R MONTEFUSCO E MANDELLI F
Citation: A. Spadea et al., PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS, Blood, 84(10), 1994, pp. 10000058-10000058
CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE (BP) IN PH-INTERFERON( CHRONIC MYELOGENOUS LEUKEMIA (CML) TREATED WITH ALPHA)
Authors: ALIMENA G MORRA E LAZZARINO M MANCINI M CEDRONE M MONTEFUSCO E MERANTE S RONDINELLI MB BERNASCONI P MELONI G BERNASCONI C MANDELLI F
Citation: G. Alimena et al., CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE (BP) IN PH-INTERFERON( CHRONIC MYELOGENOUS LEUKEMIA (CML) TREATED WITH ALPHA), Blood, 84(10), 1994, pp. 10000629-10000629
IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGONUCLEOTIDES DOES NOT AFFECT HEMATOPOIETIC RECONSTITUTION AFTER AUTOGRAFT IN PATIENTS WITH CML IN ADVANCED PHASE
Authors: DEFABRITIIS P AVVISATI G MANCINI M LISCI A MONTEFUSCO E SALA R CAMPBELL K GEISER T AMADORI S CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGONUCLEOTIDES DOES NOT AFFECT HEMATOPOIETIC RECONSTITUTION AFTER AUTOGRAFT IN PATIENTS WITH CML IN ADVANCED PHASE, Blood, 84(10), 1994, pp. 10000727-10000727
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
Risultati: 1-25 | 26-33